| abstract |
ILT4 BINDING ANTIBODIES.nThe present invention relates to antibodies that specifically bind to immunoglobulin 4 (ILT4) type transcript, which is also known as LILRB2, LIR2, MIR10 and CD85d, and nucleic acids, host cells, compositions and corresponding uses. In some embodiments, antibodies specifically bind to human ITL4, but do not bind significantly to ILT2, ILT3 or ILT5 or to other members of the LILRA or LILRB families. |